A multicentre validation study for the EU-TIRADS using histological diagnosis as a gold standard.
Pierpaolo TrimboliRose NguBenedicte RoyerLuca M GiovanellaClaude BigorgneRicard SimoPaul CarrollGilles RussPublished in: Clinical endocrinology (2019)
The cancer rate was within or close to the given range described in the EU-TIRADS guidelines. The diagnostic value was satisfactory. The results were similar in the three institutions participating in the study.